These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17316283)

  • 1. The CARI guidelines. Calcineurin inhibitors in renal transplantation: therapeutic drug monitoring.
    Trevillian P;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S57-65. PubMed ID: 17316283
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.
    McTaggart S;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S106-10. PubMed ID: 17316270
    [No Abstract]   [Full Text] [Related]  

  • 3. The CARI guidelines. Choice of calcineurin inhibitors in adult renal transplantation: effects on transplant outcomes.
    Pilmore H;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S88-97. PubMed ID: 17316287
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic monitoring of calcineurin inhibitors for the nephrologist.
    Schiff J; Cole E; Cantarovich M
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):374-84. PubMed ID: 17699437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
    Coates PT;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
    [No Abstract]   [Full Text] [Related]  

  • 6. The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors.
    Grimer M;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S98-S105. PubMed ID: 17316288
    [No Abstract]   [Full Text] [Related]  

  • 7. The CARI guidelines. Calcineurin inhibitors in renal transplantation: adverse effects.
    Jose M;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S66-74. PubMed ID: 17316284
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced exposure to calcineurin inhibitors in renal transplantation.
    Krüger B; Banas M; Hoffmann U
    N Engl J Med; 2008 Jun; 358(23):2518-9; author reply 2519-20. PubMed ID: 18536097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...].
    Fasoli G
    G Ital Nefrol; 2007; 24(2):110. PubMed ID: 17458825
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
    Blanchet B
    Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L
    G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial carcinoma in kidney transplant recipients: conversion from calcineurin inhibitor to proliferation signal inhibitor?
    Chung SD; Lai MK; Wang SM; Liao CH; Yu HJ; Chueh SC
    Am J Kidney Dis; 2008 Sep; 52(3):630; author reply 631. PubMed ID: 18725025
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring of calcineurin inhibitors induced-nephrotoxicity].
    Kamar N; Rostaing L
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S13-S17. PubMed ID: 18703392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-calcineurins (cyclosporin and tacrolimus)].
    Raymond S; Limat S; Woronoff-Lemsi MC
    Soins; 2007 Jun; (716):61-3. PubMed ID: 17718044
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus.
    Oberbauer R
    Transplantation; 2009 Apr; 87(8 Suppl):S7-10. PubMed ID: 19384186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.